Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 5Gastrointestinal 2Thoracic 1Other 1Head & Neck 1

Conditions

Rectal Neoplasms 1Prevention of Colorectal Cancer 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 328Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 257lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Selenomethionine × Gastrointestinal × Clear all
NCT00625183 2017-11-17

Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma

Roswell Park Cancer Institute

Phase 2 Terminated
5 enrolled 6 charts
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT01211561 2010-09-29

Colon Cancer Prevention Using Selenium

University of Illinois at Chicago

Phase EARLY_PHASE1 Unknown
50 enrolled
Gastrointestinal

Prevention of Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡